Innovator Growth Accelerated ETF - Quarterly (BATS: XDQQ)

Innovator Growth Accelerated ETF - Quarterly (BATS:XDQQ), Trade Ideas

Innovator Growth Accelerated ETF - Quarterly

To gain an edge, this is what you need to know today.
<img alt="" src="https://thearorareport.com/wp-content/uploads/2024/05/2024-05-14_08h51_52.png" style="height:383px; width:700px" />
<h3>Hotter Inflation Data</h3>
Please <a href="https://thearorareport.com/chart-analysis-stock-market-ppi-hotter-inflation-meme-stocks-spy-mc-05142024">click here</a> for an enlarged chart of SPDR S&amp;P 500 ETF Trust (ARCA:SPY) which represents the benchmark stock market index S&amp;P 500 (SPX).
Note the following:
<ul>
<li>The chart shows the stock market is in the resistance zone.</li>
<li>As is their pattern, the momo crowd was buying ahead of the release of the Producer Price Index (PPI) on hope strategy.</li>
<li>The momo crowd&rsquo;s hopes were dashed when PPI data came much hotter than expected.&nbsp;Here are the details:
<ul>
<li>Headline PPI came at 0.5% vs. 0.3% consensus.</li>
<li>Core PPI came at 0.5% vs. 0.2% consensus.</li>
</ul>
</li>
<li>The chart shows the stock market first dipped on bad inflation data, but as of this writing in the premarket, the momo crowd is aggressively buying the dip.</li>
<li>Prudent investors, in The Arora Report analysis, would want to wait to see Consumer Price Index (CPI) data tomorrow before taking any action.&nbsp;CPI will be released tomorrow at 8:30am ET.</li>
<li>The Arora Report <a href="https://blog.thearorareport.com/disney-050824/">previously shared</a> that the Fed&rsquo;s second blunder has loosened financial conditions way beyond where they should be based on the economic data.</li>
<li>The Fed&rsquo;s blunder is now showing up in meme stocks roaring back.&nbsp;Earlier this morning, GameStop Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gme#NYSE">GME</a>) was up 163% in the premarket on top of 74% gain yesterday.</li>
<li>The meme crowd ran up AMC Entertainment Holdings Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amc#NYSE">AMC</a>) 156% this morning, trading as high as $13.30 in the premarket.&nbsp;AMC took advantage of the meme crowd to raise about $250M of new capital by selling shares at $3.45.&nbsp;When the company is selling shares at $3.45, why would the meme crowd buy the same shares at $13.30?&nbsp; The answer is the meme crowd is not doing any analysis other than becoming a meme to cause a short squeeze.</li>
<li>The last meme craze ended in tears for the meme crowd with big losses.&nbsp;As full disclosure, The Arora Report gave a number of successful, short term signals on meme stocks, taking advantage of previous crazes.&nbsp;If the meme craze continues, The Arora Report&nbsp;will return to the same playbook.</li>
<li>In addition to GME and AMC, here are the stocks the meme crowd is targeting: Plug Power Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plug#NASDAQ">PLUG</a>), BlackBerry Ltd (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bb#NYSE">BB</a>), Eastman Kodak Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kodk#NYSE">KODK</a>), Lemonade Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lmnd#NYSE">LMND</a>), Novavax Inc&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvax#NASDAQ">NVAX</a>),&nbsp;SunPower Corporation&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spwr#NASDAQ">SPWR</a>), Tupperware Brands Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tup#NYSE">TUP</a>),&nbsp;Newegg Commerce Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/negg#NASDAQ">NEGG</a>),&nbsp;Spirit Airlines Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/save#NYSE">SAVE</a>), Hertz Global Holdings Inc&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/htz#NASDAQ">HTZ</a>), KOSS Corp&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/koss#NASDAQ">KOSS</a>),&nbsp;Reddit Inc&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rddt#NYSE">RDDT</a>),&nbsp;VinFast Auto Ltd&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vfs#NASDAQ">VFS</a>), Rivian Automotive Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rivn#NASDAQ">RIVN</a>), and&nbsp;C3.ai Inc&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ai#NYSE">AI</a>).</li>
<li>Among earnings, the most notable are earnings from Dow Jones (DJIA) component Home Depot Home Depot Inc (NYSE:&nbsp;HD).&nbsp;Here are the details:
<ul>
<li>Home Depot showed its sixth consecutive quarter of negative sales growth.</li>
<li>Same store sales decreased by 3%.</li>
<li>Earnings were roughly inline with whisper numbers.</li>
</ul>
</li>
</ul>
<h3>Layoffs</h3>
Walmart Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wmt#NYSE">WMT</a>) is laying off hundreds of corporate employees.&nbsp;Walmart is also calling remote workers back to the office.
<h3>Magnificent Seven Money Flows</h3>
In the early trade, money flows are positive in Tesla Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>).
In the early trade, money flows are neutral in Apple Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aapl#NASDAQ">AAPL</a>).
In the early trade, money flows are negative in Amazon.com, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amzn#NASDAQ">AMZN</a>), Alphabet Inc Class C (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/goog#NASDAQ">GOOG</a>), Meta Platforms Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meta#NASDAQ">META</a>), Microsoft Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/msft#NASDAQ">MSFT</a>), and NVIDIA Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvda#NASDAQ">NVDA</a>).
In the early trade, money flows are mixed in SPDR S&amp;P 500 ETF Trust (ARCA:SPY) and Invesco QQQ Trust Series 1 (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qqq#NASDAQ">QQQ</a>).
<h3>Momo Crowd And Smart Money In Stocks</h3>
The momo crowd is aggressively buying in the early trade.&nbsp;Smart money is inactive in the early trade.
<h3>Gold</h3>
The momo crowd is buying gold in the early trade. Smart money is inactive in the early trade.
For longer-term, please see gold and silver ratings.
<h3>Oil</h3>
The momo crowd is like a yoyo in oil in the early trade.&nbsp;Smart money is inactive in the early trade.
For longer-term, please see oil ratings.
<h3>Bitcoin</h3>
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is range bound.
<h3>Protection Band And What To Do Now</h3>
It is important for investors to look ahead and not in the rearview mirror.
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.
You can determine your protection bands by adding cash to hedges.&nbsp;The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.&nbsp;If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.
A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.&nbsp;A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.
It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.&nbsp;When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.&nbsp;High beta stocks are the ones that move more than the market.
<h3>Traditional 60/40 Portfolio</h3>
Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.
Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of seven year duration or less.&nbsp;Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.
The Arora Report is known for its accurate calls. The Arora Report correctly called the big artificial intelligence rally before anyone else, the new bull market of 2023, the bear market of 2022, new stock market highs right after the virus low in 2020, the virus drop in 2020, the DJIA rally to 30,000 when it was trading at 16,000, the start of a mega bull market in 2009, and the financial crash of 2008. Please click here to sign up for a free forever <a href="https://thearorareport.com/generate-wealth-newsletter-benzinga">Generate Wealth Newsletter</a>.
This article is from an unpaid external contributor. It does not represent Benzinga's reporting and has not been edited for content or accuracy.

Penny Stocks

Small Cap

$BTC

AAPL

AMZN

GOOG

KODK

KOSS

LMND

MSFT

NEGG

NVAX

NVDA

PLUG

RDDT

RIVN

SAVE

SPWR

TSLA

New Hotter Inflation Data – Momo Buys The Dip, Fed Blunder Shows Up In Roaring Meme Stocks

News

Offerings

Warner Bros. Discovery Upsizes Its Previously Announced Cash Tender Offer To An Aggregate Tender Cap Of Up To $2.5B

Needham analyst Ryan MacDonald reiterates PowerSchool Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PWSC#NYSE">PWSC</a>) with a Buy and maintains $26 price target.

Price Target

Reiteration

Analyst Ratings

PWSC

Needham Reiterates Buy on PowerSchool Holdings, Maintains $26 Price Target

Seelos Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEEL#NASDAQ">SEEL</a>) ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that its Board of Directors approved a 1-for-8 reverse stock split of its outstanding shares of common stock, to be effective as of 12:01 a.m. Eastern Time on Thursday, May 16, 2024.
The Company's common stock will begin trading on a reverse stock split-adjusted basis at the opening of the market on Thursday, May 16, 2024. Following the reverse stock split, the Company's common stock will continue to trade on the Nasdaq Capital Market under the symbol "SEEL" with the new CUSIP number, 81577F307. The reverse stock split is intended for the Company to regain compliance with the minimum bid price requirement of $1.00 per share of common stock for continued listing on the Nasdaq Capital Market.

Stock Split

SEEL

Seelos Therapeutics Approves 1-For-8 Reverse Stock Split, To Begin Trading On A Reverse Stock Split-Adjusted Basis At The Opening Of The Market On Thursday, May 16, 2024

Stephens &amp; Co. analyst Jacob Johnson reiterates Alpha Teknova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TKNO#NASDAQ">TKNO</a>) with a Overweight and maintains $5 price target.
 &nbsp;

TKNO

CORRECTION: Stephens & Co. Reiterates Overweight on Alpha Teknova, Maintains $5 Price Target

Trading Ideas

VINO

Gaucho Shares Halted On Circuit Breaker To The Upside, Stock Now Up 9.05%

Company Sees a 217% Surge in Year-To-Date Sales, Driven by Robust Distribution Networks and E-commerce Growth
MIAMI, FL / ACCESSWIRE / May 14, 2024 / Gaucho Group Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINO#NASDAQ">VINO</a>), a company that includes a growing collection of e-commerce platforms with a concentration on fine wines, luxury real estate, and leather goods and accessories (the "Company" or "Gaucho Holdings"), today announced that its wine sales in Argentina for the year to date in 2024 have increased by 217% compared to the same period last year-attributable to the expansion of the Company's distribution networks throughout Argentina and other strategic initiatives.
Critical enhancements reported by the Company includes improvements to operational infrastructure and distribution channels, the diligent efforts of its in-house wine sales management team, and contributions from the Company's Argentina e-commerce website and other distributors.
Additionally, the official devaluation of Argentina's peso has favorably impacted the cash flow within the Company's wine segment, which has remained cash flow positive throughout 2024.

Gaucho Holdings Wine Sales In Argentina For The Year To Date In 2024 Have Increased By 217% Vs Last Year; Says The Devaluation Of Argentina's Peso Has Favorably Impacted The Cash Flow Within The Co's Wine Segment

Guidance

GRFS

Grifols Q1 Net Revenues €1.63 Billion Vs €1.56 Billion YoY; Sees Q1 R&D Negative Net Investment €90.5 Million Vs (€104.7) Million YoY; Currently Working To Improve FCF Guidance In Light Of Several Ongoing Initiatives; To Hold Investor & Analysts Day On Oct 10

Benchmark analyst Robert Wasserman reiterates OmniAb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OABI#NASDAQ">OABI</a>) with a Buy and maintains $8 price target.

OABI

Benchmark Reiterates Buy on OmniAb, Maintains $8 Price Target

Whales with a lot of money to spend have taken a noticeably bullish stance on Salesforce.
Looking at options history for Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) we detected 15 trades.
If we consider the specifics of each trade, it is accurate to state that 66% of the investors opened trades with bullish expectations and 33% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $289,996 and 9, calls, for a total amount of $3,105,943.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $250.0 and $320.0 for Salesforce, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for Salesforce options trades today is 1365.31 with a total volume of 3,559.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Salesforce's big money trades within a strike price range of $250.0 to $320.0 over the last 30 days.
<h3>Salesforce 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1715701557_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CRM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$66.55</td>
<td>$63.7</td>
<td>$63.7</td>
<td>$280.00</td>
<td>$1.9M</td>
<td>893</td>
<td style="text-align: right;">716</td>
</tr>
<tr>
<td>CRM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/19/24</td>
<td>$4.75</td>
<td>$4.5</td>
<td>$4.55</td>
<td>$310.00</td>
<td>$712.1K</td>
<td>868</td>
<td style="text-align: right;">731</td>
</tr>
<tr>
<td>CRM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/21/24</td>
<td>$4.8</td>
<td>$4.75</td>
<td>$4.8</td>
<td>$300.00</td>
<td>$132.9K</td>
<td>4.4K</td>
<td style="text-align: right;">32</td>
</tr>
<tr>
<td>CRM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/21/24</td>
<td>$4.8</td>
<td>$4.7</td>
<td>$4.8</td>
<td>$300.00</td>
<td>$116.6K</td>
<td>4.4K</td>
<td style="text-align: right;">317</td>
</tr>
<tr>
<td>CRM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$4.3</td>
<td>$4.2</td>
<td>$4.2</td>
<td>$250.00</td>
<td>$108.3K</td>
<td>1.2K</td>
<td style="text-align: right;">293</td>
</tr>
</tbody>
</table>

<h3>About Salesforce</h3>
Salesforce Inc provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.
In light of the recent options history for Salesforce, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of Salesforce</h3>
<ul>
<li>With a trading volume of 1,007,455, the price of CRM is down by -0.17%, reaching $277.04.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 15 days from now.</li>
</ul>
<h3>Expert Opinions on Salesforce</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $344.0.
<ul>
<li>An analyst from Jefferies persists with their Buy rating on Salesforce, maintaining a target price of $360. </li>
<li>An analyst from Piper Sandler persists with their Neutral rating on Salesforce, maintaining a target price of $300. </li>
<li>An analyst from Needham downgraded its action to Buy with a price target of $345. </li>
<li>In a cautious move, an analyst from RBC Capital downgraded its rating to Outperform, setting a price target of $350. </li>
<li>Reflecting concerns, an analyst from Wolfe Research lowers its rating to Outperform with a new price target of $365.</li>
</ul>
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Salesforce, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

What the Options Market Tells Us About Salesforce

Whales with a lot of money to spend have taken a noticeably bearish stance on Bank of America.
Looking at options history for Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) we detected 13 trades.
If we consider the specifics of each trade, it is accurate to state that 46% of the investors opened trades with bullish expectations and 53% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $390,953 and 7, calls, for a total amount of $436,390.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $20.0 to $42.0 for Bank of America over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Bank of America's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Bank of America's whale activity within a strike price range from $20.0 to $42.0 in the last 30 days. 
<h3>Bank of America Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1715701552_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$5.1</td>
<td>$5.05</td>
<td>$5.1</td>
<td>$35.00</td>
<td>$125.9K</td>
<td>4.4K</td>
<td>300</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$11.35</td>
<td>$11.3</td>
<td>$11.3</td>
<td>$28.00</td>
<td>$113.0K</td>
<td>20.0K</td>
<td>100</td>
</tr>
<tr>
<td>BAC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$0.43</td>
<td>$0.42</td>
<td>$0.43</td>
<td>$37.00</td>
<td>$105.8K</td>
<td>20.7K</td>
<td>2.4K</td>
</tr>
<tr>
<td>BAC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/19/24</td>
<td>$1.18</td>
<td>$1.16</td>
<td>$1.18</td>
<td>$38.00</td>
<td>$76.7K</td>
<td>2.6K</td>
<td>652</td>
</tr>
<tr>
<td>BAC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/20/24</td>
<td>$4.1</td>
<td>$4.05</td>
<td>$4.1</td>
<td>$42.00</td>
<td>$62.7K</td>
<td>155</td>
<td>147</td>
</tr>
</tbody>
</table>

<h3>About Bank of America</h3>
Bank of America is one of the largest financial institutions in the United States, with more than $3.0 trillion in assets. It is organized into four major segments: consumer banking, global wealth and investment management, global banking, and global markets. Bank of America's consumer-facing lines of business include its network of branches and deposit-gathering operations, retail lending products, credit and debit cards, and small-business services. The company's Merrill Lynch operations provide brokerage and wealth-management services, as does its private bank. Wholesale lines of business include investment banking, corporate and commercial real estate lending, and capital markets operations. Bank of America has operations in several countries but is primarily US-focused.
<h3>Where Is Bank of America Standing Right Now?</h3>
<ul>
<li>With a trading volume of 7,321,838, the price of BAC is up by 1.14%, reaching $38.65.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 63 days from now.</li>
</ul>
<h3>Expert Opinions on Bank of America</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $42.1.
<ul>
<li>An analyst from Wolfe Research has elevated its stance to Outperform, setting a new price target at $42. </li>
<li>Maintaining their stance, an analyst from Oppenheimer continues to hold a Outperform rating for Bank of America, targeting a price of $46. </li>
<li>An analyst from JP Morgan persists with their Overweight rating on Bank of America, maintaining a target price of $40. </li>
<li>An analyst from BMO Capital persists with their Market Perform rating on Bank of America, maintaining a target price of $37. </li>
<li>An analyst from Oppenheimer persists with their Outperform rating on Bank of America, maintaining a target price of $45. </li>
</ul>
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Bank of America, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Looking At Bank of America's Recent Unusual Options Activity

High-rolling investors have positioned themselves bullish on Exxon Mobil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in XOM often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 15 options trades for Exxon Mobil. This is not a typical pattern.
The sentiment among these major traders is split, with 46% bullish and 20% bearish. Among all the options we identified, there was one put, amounting to $29,360, and 14 calls, totaling $730,442.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $70.0 to $135.0 for Exxon Mobil over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Exxon Mobil stands at 4004.67, with a total volume reaching 3,412.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Exxon Mobil, situated within the strike price corridor from $70.0 to $135.0, throughout the last 30 days.
<h3>Exxon Mobil Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1715701547_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>XOM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$7.25</td>
<td>$6.3</td>
<td>$7.21</td>
<td>$110.00</td>
<td>$136.9K</td>
<td>163</td>
<td>251</td>
</tr>
<tr>
<td>XOM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$1.46</td>
<td>$1.4</td>
<td>$1.44</td>
<td>$116.00</td>
<td>$69.5K</td>
<td>3.8K</td>
<td>512</td>
</tr>
<tr>
<td>XOM</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>05/17/24</td>
<td>$1.46</td>
<td>$1.4</td>
<td>$1.43</td>
<td>$116.00</td>
<td>$69.0K</td>
<td>3.8K</td>
<td>1.0K</td>
</tr>
<tr>
<td>XOM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$20.35</td>
<td>$20.15</td>
<td>$20.22</td>
<td>$97.50</td>
<td>$58.6K</td>
<td>271</td>
<td>80</td>
</tr>
<tr>
<td>XOM</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/21/24</td>
<td>$20.3</td>
<td>$20.0</td>
<td>$20.15</td>
<td>$97.50</td>
<td>$58.4K</td>
<td>271</td>
<td>51</td>
</tr>
</tbody>
</table>

<h3>About Exxon Mobil</h3>
ExxonMobil is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2023, it produced 2.4 million barrels of liquids and 7.7 billion cubic feet of natural gas per day. At the end of 2023, reserves were 16.9 billion barrels of oil equivalent, 66% of which were liquids. The company is one the world's largest refiners with a total global refining capacity of 4.5 million barrels of oil per day and is one of the world's largest manufacturers of commodity and specialty chemicals.
Following our analysis of the options activities associated with Exxon Mobil, we pivot to a closer look at the company's own performance.
<h3>Current Position of Exxon Mobil</h3>
<ul>
<li>Trading volume stands at 4,220,208, with XOM's price down by -0.31%, positioned at $116.6.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 73 days.</li>
</ul>
<h3>What The Experts Say On Exxon Mobil</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $137.4.
<ul>
<li>Maintaining their stance, an analyst from UBS continues to hold a Buy rating for Exxon Mobil, targeting a price of $152. </li>
<li>Consistent in their evaluation, an analyst from Mizuho keeps a Neutral rating on Exxon Mobil with a target price of $128. </li>
<li>An analyst from HSBC persists with their Hold rating on Exxon Mobil, maintaining a target price of $120. </li>
<li>Maintaining their stance, an analyst from Piper Sandler continues to hold a Overweight rating for Exxon Mobil, targeting a price of $145. </li>
<li>Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on Exxon Mobil with a target price of $142. </li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Exxon Mobil options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Smart Money Is Betting Big In XOM Options

StoneCo Ltd.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STNE#NASDAQ">STNE</a>) shares are trading lower after&nbsp;it reported&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/05/g38799981/stoneco-reports-first-quarter-2024-results" rel="noreferrer noopener">first-quarter FY24 results</a>.
Revenue and Income of R$3.08 billion missed the consensus of R$3.09 billion.&nbsp;
Revenue grew 13.8% Y/Y, led by a 16.0% Y/Y increase in financial services revenues, aided by active client base growth and higher monetization from clients in the MSMB&nbsp;(Micro and SMB clients) segment.
Consolidated Total Payment Volume (TPV), including PIX P2M transactions, grew 17.9% Y/Y&nbsp;to R$114.3 billion in the quarter, led by the MSMB segment&#8217;s TPV (+18.4% Y/Y) and a 147.7% Y/Y increase in PIX P2M volumes.
Monthly Average TPV MSMB fell 12.7% Y/Y in the first quarter of FY24.&nbsp;Clients Deposits&nbsp;stood at R$6.0 billion, up 53.4% Y/Y, in the quarter.
Adjusted EBITDA increased 20.8% Y/Y to R$1.51 billion, with a margin of 49.0% (up 2.9ppt Y/Y). Adjusted EPS of R$1.42 missed <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">the consensus of R$1.44</a>.
Adjusted net cash position stood at R$5.14 billion in the first quarter of FY24, increasing 28.9% Y/Y.
Outlook: For FY24, the company expects MSMB TPV&nbsp;to be &gt;R$412 billion in FY24 and&nbsp;&gt;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">R$600 billion in FY27</a>.
Investors can gain exposure to the stock via&nbsp;Gabelli ETFs Trust Gabelli Financial Services Opportunities ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GABF#NYSE">GABF</a>) and&nbsp;First Trust Brazil AlphaDEX Fund&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBZ#NASDAQ">FBZ</a>).
Price Action: STNE shares are down 9.88% at $15.01&nbsp;at&nbsp;the last check Tuesday.

Earnings

Equities

Mid Cap

Movers

Gabelli ETFs Trust Gabelli Financial Services Opportunities ETF

GABF

STNE

Why Is Fintech Company StoneCo Stock Trading Lower Today?

Cisco Systems Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) last month announced the launch of Hypershield for increasing the security<a href="https://www.benzinga.com/markets/equities/24/04/38318704/cisco-unveils-ai-powered-hypershield-one-of-the-most-significant-security-innovations-in-our-his"> of data centers and clouds</a>.
The company is scheduled to report its <a href="https://www.benzinga.com/calendars/earnings">fiscal third-quarter results on Wednesday</a>. Here are some key analyst previews.
Piper Sandler On Cisco Systems
Analyst James Fish maintained a Neutral rating and price target of $51.
Cisco Systems' booking trends have returned to their longer-term average and checks suggest a beat of around 1% for the quarter, Fish said in a note. The company's Networking segment faces tough comps in the quarter, "offset slightly by easy Security and Collaboration compares," he added.
This will be the first quarter to include a contribution from the Splunk acquisition, which "should help Security and Observability materially accelerate on a reported basis," the analyst wrote. The latest reduction in guidance has created "a more attractive setup given revenue reaccelerating from the Splunk deal," he added.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
JPMorgan On Cisco Systems
Analyst Samik Chatterjee reiterated a Neutral rating and price target of $53.
Revenue trends at Cisco Systems' Networking segment seem to be tracking in-line with "already lowered expectations" and could stabilize at the low end in the fiscal fourth quarter, Chatterjee said. This would limit the need for further downgrades to expectations, despite trends tracking below seasonal, he added.
Order declines in "high-single-digit percentages or higher" on a year-on-year basis could dampen investor enthusiasm around a swift rebound, the analyst stated. Cisco Systems is unlikely to provide "some early visibility" into full-year 2025 expectations when it reports its quarterly earnings, he further wrote.
CSCO Price Action: Shares of Cisco Systems were down 0.53% to $48.42 at the time of publication on Tuesday.
Now Read: <a href="https://www.benzinga.com/short-sellers/24/05/38817374/gamestop-stock-skyrockets-as-roaring-kitty-returns-is-gme-short-squeeze-2-0-imminent">GameStop Stock Skyrockets As &#8216;Roaring Kitty&#8217; Returns: Is GME Short Squeeze 2.0 Imminent?</a>
Photo: Shutterstock

Analyst Color

Earnings Misses

Tech

CSCO

Cisco Systems Q3 Preview: Analysts Anticipate 'Stabilizing Core Business Trends'

Piper Sandler analyst Kevin Barker maintains Rithm Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RITM#NYSE">RITM</a>) with a Neutral and raises the price target from $10.5 to $12.5.

RITM

Piper Sandler Maintains Neutral on Rithm Capital, Raises Price Target to $12.5

WIIM

VUZI

Vuzix shares are trading higher after the company announced it signed a multi-phase development contract with Garmin for next-generation nano-imprinted waveguide-based display system. The stock may be trading higher amid strength in high-short interest stocks after retail trader 'Roaring Kitty' returned to social media.

Benchmark analyst Bruce Jackson reiterates Biolase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOL#NASDAQ">BIOL</a>) with a Speculative Buy and maintains $0.4 price target.

BIOL

Benchmark Reiterates Speculative Buy on Biolase, Maintains $0.4 Price Target

Piper Sandler analyst Scott Siefers maintains Truist Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFC#NYSE">TFC</a>) with a Neutral and raises the price target from $38 to $41.

Piper Sandler Maintains Neutral on Truist Finl, Raises Price Target to $41

This article was originally published on <a href="https://www.leafly.com/news/health/weed-teen-mental-health-2024-analysis">Leafly.com</a> and appears here with permission.
If you read this January 10&nbsp;<a href="https://www.wsj.com/us-news/marijuana-depression-psychosis-869490d1" rel="noreferrer noopener" target="_blank">Wall Street Journal&nbsp;piece</a>, you might conclude that a wave of cannabis-induced psychosis among teenagers is sweeping the country. The story highlights research on the correlation between cannabis use and conditions like schizophrenia and bipolar disorder. It suggests access to higher-potency cannabis is leading to ever-increasing rates of psychosis in teens.&nbsp;
But the actual data paints a different picture. Population studies of&nbsp;<a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2800728#:~:text=Conclusions%20and%20Relevance%20In%20this,of%20psychosis%2Drelated%20health%20outcomes">over 63 million people</a>&nbsp;show that rates of psychosis do not go up amid legalization.&nbsp;<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960330/" rel="noreferrer noopener" target="_blank">Teen use rates of marijuana are actually going down</a>. And our best science suggests that genetic factors&mdash;rather than cannabis use&mdash;are to blame for the correlation between cannabis and psychosis.&nbsp;
Can cannabis really induce life-long psychotic conditions&mdash;or is this yet another example of confusing correlation with causation, a common source of &ldquo;reefer madness?&rdquo;
<h3 id="h-exploring-cannabis-psychosis-links">Exploring Cannabis-Psychosis Links</h3>
The research on cannabis and psychosis is nuanced, but it definitely shows a strong correlation&mdash;as opposed to a&nbsp;causation&mdash;between the two. For instance, the data is clear that acute cannabis exposure&nbsp;<a href="https://www.nature.com/articles/1300496" rel="noreferrer noopener" target="_blank">can cause you to see vivid colors, or mis-hear sounds, or get anxious</a>. These experiences have been described as transitory &ldquo;psychosis-like&rdquo; episodes&mdash;particularly for&nbsp;<a href="https://academic.oup.com/ijnp/article/23/9/559/5834890?login=false" rel="noreferrer noopener" target="_blank">occasional users</a>.&nbsp;
<h3 id="h-confusing-correlation-with-causation">Confusing Correlation With Causation</h3>
With that in mind, it might not be surprising that when teens who use cannabis develop permanent psychosis-related conditions, their doctors and loved ones jump to the conclusion that cannabis caused the shift. There are numerous stories of teens who used cannabis and were subsequently diagnosed with these challenging, life-long conditions. Statistically, individuals who use cannabis&nbsp;<a href="https://www.thelancet.com/article/S2215-0366(19)30048-3/fulltext#:~:text=Daily" rel="noreferrer noopener" target="_blank">are more likely to have bipolar disorder or schizophrenia than the general population</a>.&nbsp;
But scientists have long struggled with the question of whether cannabis use actually causes these conditions&mdash;or if a third factor drives both. Based on cases where these conditions emerge&nbsp;after&nbsp;cannabis use, researchers&nbsp;<a href="https://www.sciencedirect.com/science/article/abs/pii/B9780128047910000082" rel="noreferrer noopener" target="_blank">estimate that cannabis-induced psychosis occurs in .0027% of consumers</a>. But even at this exceptionally rare rate, correlative studies can&rsquo;t prove whether cannabis is the cause of psychosis or not.&nbsp;
There are many ways to interpret the data that associate cannabis with psychosis. For example, individuals with psychosis conditions could be more likely to use cannabis in the first place, as a form of self-medication. If this were true, it would result in the same strong correlation.
<h3 id="h-other-correlates-alcohol-tobacco">Other Correlates: Alcohol, Tobacco</h3>
Cannabis certainly isn&rsquo;t the only factor linked with psychosis, even though it receives more publicity. Studies have found many things correlate with higher risk of psychosis,&nbsp;including the use of any recreational substance, like&nbsp;<a href="https://www.ncbi.nlm.nih.gov/books/NBK459134/" rel="noreferrer noopener" target="_blank">alcohol</a>&nbsp;and&nbsp;<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604123/" rel="noreferrer noopener" target="_blank">tobacco</a>. These substances are used&nbsp;<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035998/#:~:text=Individuals%20with%20schizophrenia%2Fpsychosis%20also,%25%2C%20p%3C0.001)." rel="noreferrer noopener" target="_blank">at similar rates</a>&nbsp;by schizophrenics as cannabis, and show similar statistical increases in psychosis risk. No one is debating, however, whether we should prohibit these substances.&nbsp;
<h3 id="h-life-stressors">Life Stressors</h3>
<a href="https://www.healthline.com/health/stress-induced-psychosis#treatment" rel="noreferrer noopener" target="_blank">Stress</a>&nbsp;also frequently correlates to psychosis. The stress associated with an event like a teenager leaving home to begin college can trigger an initial psychotic episode.
One&nbsp;<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775150/" rel="noreferrer noopener" target="_blank">review study</a>&nbsp;found that the strongest factors correlated with developing lasting psychosis include a) living in an urban area and b) being an ethnic minority. Since cannabis is often used to combat stress, it&rsquo;s possible that people who are stressed out enough to develop psychosis are more likely to seek out cannabis.
<h3 id="h-spice-k-2-and-designer-drugs-nbsp">Spice, K-2, And Designer Drugs&nbsp;</h3>
And lastly, studies that associate cannabis with psychosis don&rsquo;t specify which specific cannabinoids are at play. For example, businesses like head shops and truck stops sell unlicensed, unregulated&mdash;and often illegal&mdash;synthetic cannabinoids (<a href="https://www.leafly.com/news/cannabis-101/what-is-thc-o">THC-O</a>,&nbsp;<a href="https://www.leafly.com/news/science-tech/thcp-cbdp-study-reveals-identification-two-new-cannabinoids">THC-P</a>,&nbsp;<a href="https://www.leafly.com/news/strains-products/what-is-hhc">HHC</a>, etc.) that can be hundreds of times more powerful than THC alone.&nbsp;
The use of dangerous synthetics like&nbsp;<a href="https://www.leafly.com/news/cannabis-101/what-is-synthetic-marijuana-and-why-is-it-dangerous">Spice</a>&nbsp;prevails in states that lack access to legal botanical THC. Athletic and military THC testing regimes also induce players and servicemembers to seek out novel, dangerous synthetics that won&rsquo;t show up in a drug test.
Data suggests that using synthetic cannabinoids&nbsp;<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450675/" rel="noreferrer noopener" target="_blank">can induce more symptoms of psychosis</a>&nbsp;than natural cannabis.
<h2 id="h-legalization-isn-t-increasing-teen-use">Legalization Isn&rsquo;t Increasing Teen Use</h2>
Some research also suggests that cannabis use among teenagers in particular&nbsp;<a href="https://pubmed.ncbi.nlm.nih.gov/33617756/" rel="noreferrer noopener" target="_blank">has a strong correlation with a subsequent diagnosis of a psychosis-related condition</a>. This could mean that teens are particularly vulnerable to cannabis&rsquo; effects. But it could also point towards the fact that conditions like&nbsp;<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266753/" rel="noreferrer noopener" target="_blank">bipolar disorder</a>&nbsp;and&nbsp;<a href="https://www.nimh.nih.gov/health/statistics/schizophrenia" rel="noreferrer noopener" target="_blank">schizophrenia</a>&nbsp;are most commonly identified and diagnosed while patients are in their twenties, while&nbsp;<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593777/#:~:text=For%20cannabis%20initiation%2C%20reported%20ages,SD%3D3.2)%20for%20women." rel="noreferrer noopener" target="_blank">cannabis use usually begins during teenage years</a>. It is possible that individuals with these conditions would be more likely to self-medicate with cannabis; since this typically occurs before their diagnosis, doctors and scientists would assume that cannabis&nbsp;caused&nbsp;the psychosis-like condition.
While many prohibitionists would use any potential for teen psychosis as a reason to limit cannabis legalization, it&rsquo;s important to note that&nbsp;<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960330/" rel="noreferrer noopener" target="_blank">rates of teen cannabis use are going down,</a>&nbsp;not up, as states legalize cannabis. Street dealers do not check ID, but legitimate dispensaries do. This means that legalization tends to limit teen access, rather than increasing it.&nbsp;
<h2 id="h-psychosis-rates-do-not-increase-with-cannabis-legalization-nbsp">Psychosis Rates *Do Not* Increase With Cannabis Legalization&nbsp;</h2>
Fortunately, scientists dig deeper than simple correlative studies. For instance, they look at the rates of psychosis in places where cannabis is more available. If cannabis&rsquo; prevalence causes psychosis, it would follow that as cannabis access increases, we would see rising rates of psychosis.&nbsp;
While legalization&nbsp;does&nbsp;increase rates of other conditions that are directly triggered by cannabis use, such as&nbsp;<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624147/#:~:text=Previous%20studies%20have%20shown%20an,Colorado%20EDs%20after%20cannabis%20legalization." rel="noreferrer noopener" target="_blank">cannabinoid hyperemesis syndrome</a>, the studies that examine psychosis rates have had very mixed results.&nbsp;
The&nbsp;WSJ&nbsp;article mentioned earlier in this article cites a&nbsp;<a href="https://www.thelancet.com/article/S2215-0366(19)30048-3/fulltext" rel="noreferrer noopener" target="_blank">small Danish study</a>&nbsp;that examined data collected from 6,788 people in 11 locations throughout Europe and Brazil. None had access to tested, legal cannabis.
While it did find a link between access to high-potency cannabis and psychosis, a&nbsp;<a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2800728#:~:text=Conclusions%20and%20Relevance%20In%20this,of%20psychosis%2Drelated%20health%20outcomes" rel="noreferrer noopener" target="_blank">much larger US study</a>&nbsp;involving over 63 million people found that access to medical or recreational cannabis had no impact on psychosis rates at all. If we were seeing a dramatic wave of teen psychosis in the US, as suggested in the recent&nbsp;WSJ&nbsp;piece, that shift should be reflected in this large-scale population study.&nbsp;
<h2 id="h-genetics-may-drive-cannabis-use-as-well-as-mental-health-outcomes-nbsp">Genetics May Drive Cannabis Use As Well As mental Health Outcomes&nbsp;</h2>
Psychosis rates haven&rsquo;t skyrocketed with the recent increase in legal cannabis access, so why do we see any correlation between the two?&nbsp;
Beyond the possibilities suggested above, genetics may play a key role. Scientists have found data that points to&nbsp;<a href="https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2021.21111126" rel="noreferrer noopener" target="_blank">underlying genes that predispose someone to both psychosis and cannabis-use disorder</a>. (Doctors&nbsp;<a href="https://www.ncbi.nlm.nih.gov/books/NBK538131/" rel="noreferrer noopener" target="_blank">diagnose cannabis-use disorder</a>&nbsp;when someone experiences negative effects from cannabis use, wants to stop using it, but cannot bring themselves to quit despite repeated efforts.)
Research reviews have found that an individual who has genetics correlated with cannabis-use disorder may be more likely to develop schizophrenia,&nbsp;whether or not they actually ever used cannabis.&nbsp;This suggests that genetics, rather than cannabis, is to blame.&nbsp;
One the best-designed studies just came out. In January, researchers published a&nbsp;<a href="https://psycnet.apa.org/record/2024-40025-005">rare study of more than 4,000 identical twins</a>&nbsp;over time. One twin used weed while the other didn&rsquo;t, and researchers tracked them for 27 years. Weed use did not predict mental health outcomes.
&ldquo;Cannabis consumption did not predict within-pair differences in psychoticism,&rdquo; the researchers concluded.
There&rsquo;s a big takeaway here: If you have a family history of mental illness, and are increasing your cannabis use, you might want to re-evaluate your habits.
The data also supports maintaining 21 as the legal appropriate age for cannabis consumption; that&rsquo;s typically towards the back end of when congenital mental illness may crop up in an individual.&nbsp;
While more research may shift our understanding of these issues, the current data does not suggest that cannabis use is a strong causal factor for chronic mental illness. Still, given cannabis&rsquo; ability to cause visual effects or strange thoughts, THC may be best avoided by at-risk patients. At the same time, doctors are actively evaluating whether the cannabinoid CBD can treat mental illnesses.&nbsp;
As always, consult with a cannabis-specializing doctor before beginning medical use of cannabis to treat your symptoms. &nbsp;
This article is from an external unpaid contributor. It does not represent Benzinga&#39;s reporting and has not been edited for content or accuracy.

Cannabis

General

Fact Check: Is Marijuana Legalization Hurting Teen Mental Health?

Piper Sandler analyst Ryan Todd maintains PBF Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBF#NYSE">PBF</a>) with a Neutral and lowers the price target from $61 to $54.

Piper Sandler Maintains Neutral on PBF Energy, Lowers Price Target to $54

Quality Growth Shines

3 Value Equity Themes For The End Of 2023

Select Segments Of Growth Still Providing Steady Returns

Growth Stocks Are Less Expensive Than Traditional Measures Imply

Latest Memo From Howard Marks: Further Thoughts On Sea Change

Value's U-Turn

Capital Markets Outlook: Q1 2024

Stocks Likely To 'Take Five'

Why Stocks Can Survive Bond Market Bumps

Overlook Style Regimes At Your Peril

ABEQ

ACTV

AFMC

AFSM

AIEQ

AIRR

AIVL

ALTL

AMOM

ANEW

ARKF

ARKK

ARKQ

ARKW

ARKX

ATFV

AUSF

AVUV

BAPR

BAUG

BBJP

BBMC

BBSC

BFOR

BJUL

BJUN

BKMC

BKSE

BLCN

BLOK

BMAR

BMAY

BMVP

BOCT

BOTZ

BOUT

BTEK

BUFF

CACG

CALF

CATH

CBSE

CFCV

CIBR

CLOU

CLRG

COWZ

CSML

CSTNL

DAPP

DBJP

DDIV

DEEP

DEUS

DFAS

DFNV

DGRO

DGRS

DIVB

DIVY

DIVZ

DTEC

DURA

DVLU

DWAS

DWAW

DWUS

DXJS

EDOW

EFIV

EFRA

ENTR

EQAL

EQRR

ESGS

ESML

ESPO

ETHO

EWJV

FBCG

FBCV

FBGX

FDMO

FDRR

FDVV

FFTY

FGRO

FIDU

FINX

FITE

FLJH

FLJP

FLQM

FLQS

FMAG

FNDA

FNDB

FNDX